We next utilised the 3LL-ΔNRAS transplantable mouse model to evaluate responses to RMC-4998 and RMC-4550 and the potential for combination with immunotherapies in an immune-excluded, anti-PD-1 resistant lung cancer model. Here, PDCD1 is linked to lung carcinoma.